KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 125 filers reported holding KEROS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,903,325 | +103.8% | 718,423 | +156.9% | 0.27% | +102.3% |
| Q2 2023 | $11,238,386 | +32.8% | 279,701 | +41.2% | 0.13% | +15.7% |
| Q1 2023 | $8,460,535 | -10.4% | 198,139 | +0.7% | 0.12% | -8.7% |
| Q4 2022 | $9,445,486 | -26.7% | 196,699 | -42.6% | 0.13% | -30.0% |
| Q3 2022 | $12,885,000 | -7.9% | 342,493 | +33.2% | 0.18% | -20.7% |
| Q1 2022 | $13,987,000 | +213.7% | 257,200 | +237.5% | 0.23% | +254.7% |
| Q4 2021 | $4,459,000 | -40.0% | 76,212 | -59.4% | 0.06% | -47.1% |
| Q3 2021 | $7,431,000 | – | 187,835 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |